Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Bayer plc, 400 South Oak Way, Reading, RG2 6AD
Glucobay 50 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet for oral administration. White to yellow-tinged round, convex tablets of 7 mm diameter and 10 mm radius of curvature with ‘G50’ on one side and the BAYER-cross on the other side. |
Glucobay 50 mg tablets: 1 tablet contains 50 mg acarbose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Acarbose |
Acarbose is an alpha-glucosidase inhibitors, used in the treatment of diabetes. Inhibitors of a-glucosidase retard the breakdown of carbohydrates in the food and reduce the increase in blood glucose levels, which occurs after each meal. |
| List of Excipients |
|---|
|
Glucobay tablets contain the following excipients: Microcrystalline cellulose |
Blister strips comprising 300μm polypropylene foil (colourless) with a 20μm soft aluminium backing foil, in cardboard outers.
Pack sizes: 90.
Bayer plc, 400 South Oak Way, Reading, RG2 6AD
PL 00010/0171
28 May 1993 / 16 February 2004
| Drug | Countries | |
|---|---|---|
| GLUCOBAY | Austria, Australia, Brazil, Canada, Estonia, Spain, Hong Kong, Italy, Japan, Mexico, Netherlands, Poland, Romania, Singapore, Turkey |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
